Treatment of Gilles de la Tourette's syndrome: eight-year, practice-based experience in a predominantly adult population.

Author: MesulamM M, PetersenR C

Paper Details 
Original Abstract of the Article :
Over 86% of 58 patients with Gilles de la Tourette's syndrome achieved effective pharmacologic control of the symptoms for 3 months or longer. Differences in response patterns were common among patients and required individualized tailoring of management. Dopamine-blocking neuroleptics were the main...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1212/wnl.37.12.1828

データ提供:米国国立医学図書館(NLM)

Gilles de la Tourette's Syndrome: Tailoring Treatment for a Complex Condition

The human brain is an intricate and fascinating organ, and conditions affecting its function can be a significant challenge. Gilles de la Tourette's syndrome (TS) is a neurological disorder characterized by involuntary movements and vocalizations. This research delves into the treatment of TS, exploring the effectiveness of various pharmacologic approaches. The authors share their experience treating a predominantly adult population with TS, highlighting the importance of individualized care and the frequent need for adjustments in treatment plans. They emphasize the use of dopamine-blocking neuroleptics as a primary treatment modality, but also acknowledge the need for flexibility and personalized approaches to address individual patient needs.

Finding the Right Balance for Patients

Treatment of TS is like navigating a delicate balance between controlling symptoms and minimizing side effects. The authors emphasize the need for individualized care and frequent adjustments to treatment plans, reflecting the complex nature of this condition. The use of dopamine-blocking neuroleptics, while a common approach, requires careful monitoring to ensure optimal efficacy and minimal side effects. This highlights the importance of close collaboration between patients and healthcare professionals in managing TS.

Embracing Individuality

Just as the diverse landscapes of the desert reflect unique beauty, so too do individuals with TS exhibit a range of symptoms and responses to treatment. This study emphasizes the importance of individualizing treatment plans and recognizing that what works for one person may not work for another. By embracing this individuality, healthcare professionals can better support those living with TS.

Dr.Camel's Conclusion

The authors have shared valuable insights into the intricacies of treating TS. Their work emphasizes the importance of personalized care and the ongoing need to adapt treatment strategies as individual needs evolve. By understanding the unique characteristics of each patient, healthcare professionals can provide the best possible support and management for those living with TS.

Date :
  1. Date Completed 1987-12-28
  2. Date Revised 2019-05-14
Further Info :

Pubmed ID

3479704

DOI: Digital Object Identifier

10.1212/wnl.37.12.1828

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.